DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
Q1 2024 vs. Q4 2023
How the institutions holding DBV Technologies S.A. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 40 | 33 | −7 |
| Shares | 37.7M | 37.7M | −22.2K (−0.1%) |
| Value | $35.9M | $28.3M | −$7.63M (−21.2%) |
New holders (2)
Institutions that held DBV Technologies S.A. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 12,618 | $9.54K | 0.00% |
| Optiver Holding B.V. | 6 | $4 | 0.00% |
Sold out (9)
Institutions that held DBV Technologies S.A. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Jane Street Group, LLC | 59,307 | $56.5K |
| Commonwealth Equity Services, LLC | 17,878 | $17.0K |
| CoreCap Advisors, LLC | 13,478 | $12.8K |
| Old Mission Capital LLC | 13,379 | $12.7K |
| Virtu Financial LLC | 12,555 | $12.0K |
| Susquehanna International Group, LLP | 10,671 | $10.2K |
| Tower Research Capital LLC (TRC) | 7,650 | $7.29K |
| Advisory Services Network, LLC | 1,300 | $1.24K |
| Annapolis Financial Services, LLC | 270 | $258 |